Bone Modifiers - Teriparatide Products
Customize your policy alerts
Sign up for Cigna Policy IP0330 alerts
Get alerted when Policy IP0330 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical-necessity coverage for Bonsity, Forteo, and teriparatide subcutaneous injections. It applies to Cigna-administered health benefit plans and establishes indication-specific clinical, prior-treatment, duration, and preferred-product requirements.
Chronic hypoparathyroidism was removed as a condition of approval.
Bonsity was added to the coverage policy and preferred-product criteria.
Product availability descriptions for Forteo and teriparatide were updated from 600 mcg/2.4 mL to 560 mcg/2.24 mL.
Preferred-product criteria were revised to address inactive-ingredient differences and use of the terms 'tried and cannot take.'
An exception was added allowing individual and family plan members with glucocorticoid-induced osteoporosis to bypass the Tymlos trial requirement.
Criteria were added for approval when patients cannot take oral bisphosphonates or have severe renal impairment.
An exception was added allowing a postmenopausal patient with a very low T-score below -3.0 to bypass a bisphosphonate trial.
Calcium and/or vitamin D supplements were expressly identified as permissible with teriparatide despite the concurrent-use exclusion for other osteoporosis medications.
Acute post-surgical hypoparathyroidism and hypoparathyroidism caused by calcium-sensing receptor mutations were removed from conditions not covered.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.